Company Data
Pliant Therapeutics Inc.
Ticker
PLRX
Current Price
$1.35 -1.46%
Market Cap
$82.9M
Price Target
Refer to Report
Volume
2.7M
52wk Range
$1.1001 - $16.1
Overview
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.